NuCana Plc (NCNA)
1.02
-0.03
(-2.86%)
USD |
NASDAQ |
Oct 15, 16:00
1.00
-0.02
(-1.96%)
After-Hours: 20:00
NuCana Cash from Operations (TTM) : -6.332M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -6.332M |
| March 31, 2026 | -9.619M |
| December 31, 2025 | -9.412M |
| September 30, 2025 | -17.94M |
| June 30, 2025 | -25.28M |
| March 31, 2025 | -20.77M |
| December 31, 2024 | -24.19M |
| September 30, 2024 | -13.89M |
| June 30, 2024 | -20.98M |
| March 31, 2024 | -26.89M |
| December 31, 2023 | -31.76M |
| September 30, 2023 | -39.66M |
| June 30, 2023 | -24.19M |
| March 31, 2023 | -28.16M |
| December 31, 2022 | -27.52M |
| September 30, 2022 | -33.74M |
| Date | Value |
|---|---|
| June 30, 2022 | -37.41M |
| March 31, 2022 | -33.00M |
| December 31, 2021 | -32.58M |
| September 30, 2021 | -30.77M |
| June 30, 2021 | -35.95M |
| March 31, 2021 | -30.70M |
| December 31, 2020 | -27.29M |
| September 30, 2020 | -19.80M |
| June 30, 2020 | -23.62M |
| March 31, 2020 | -28.88M |
| December 31, 2019 | -28.71M |
| September 30, 2019 | -27.13M |
| June 30, 2019 | -21.87M |
| March 31, 2019 | -19.07M |
| December 31, 2018 | -15.10M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Biodexa Pharmaceuticals Plc | -9.219M |
| Mereo BioPharma Group Plc | -25.28M |
| BioNTech SE | 725.62M |
| Silence Therapeutics Plc | -41.79M |
| Compass Pathways Plc | -160.76M |